Trial Site Detail
Drug: |
Perifosine + Sunitinib |
|||
|---|---|---|---|---|
Trial: |
Perifosine + Sunitinib Malate for Patients With Advanced Cancers |
|||
| Conditions: | Renal Cancer; GIST | |||
Trial Status: |
Completed |
|||
Tower Cancer Research Foundation9090 Wilshire Blvd Suite 350 |
Principal Investigator: |
|
|---|---|
Contact: |
415-946-2410, ocogtrials@ocog.net |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Tower Cancer Research Foundation Website: |
http://www.towercancerfoundation.org/TCRF_contact_information.php |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.